You are here:

Jenna's treatment story: Mavenclad

Published on

Jenna, 29, was diagnosed with relapsing remitting MS in 2017, just two weeks before Christmas. After three years on one of the injectable disease modifying drugs, Jenna was forced to consider changing her treatment following a relapse shortly after the birth of her baby.

Here Jenna talks about why she chose to switch to Mavenclad and how she’s found the treatment so far.

tablets

I’ve found Mavenclad to be quite a convenient treatment to be on. It's nice to do a course of tablets and then not have to worry and not have to remember to take anything else.

Print this page